Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 2
2007 2
2011 2
2012 2
2013 6
2014 1
2016 1
2018 3
2020 1
2021 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma.
Reddel HK, O'Byrne PM, FitzGerald JM, Barnes PJ, Zheng J, Ivanov S, Lamarca R, Puu M, Alagappan VKT, Bateman ED. Reddel HK, et al. Among authors: alagappan vkt. J Allergy Clin Immunol Pract. 2021 Aug;9(8):3069-3077.e6. doi: 10.1016/j.jaip.2021.04.016. Epub 2021 Apr 22. J Allergy Clin Immunol Pract. 2021. PMID: 33895362 Free article. Clinical Trial.
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.
O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zheng J, Gustafson P, Lamarca R, Puu M, Keen C, Alagappan VKT, Reddel HK. O'Byrne PM, et al. Among authors: alagappan vkt. Lancet Respir Med. 2021 Feb;9(2):149-158. doi: 10.1016/S2213-2600(20)30416-1. Epub 2020 Oct 1. Lancet Respir Med. 2021. PMID: 33010810 Clinical Trial.
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies.
FitzGerald JM, O'Byrne PM, Bateman ED, Barnes PJ, Zheng J, Ivanov S, Lamarca R, Larsdotter U, Emerath U, Jansen G, Puu M, Alagappan VKT, Surmont F, Reddel HK. FitzGerald JM, et al. Among authors: alagappan vkt. Drug Saf. 2021 Apr;44(4):467-478. doi: 10.1007/s40264-020-01041-z. Epub 2021 Feb 6. Drug Saf. 2021. PMID: 33548020 Free PMC article. Clinical Trial.
Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD.
Watz H, Bagul N, Rabe KF, Rennard S, Alagappan VK, Román J, Facius A, Calverley PM. Watz H, et al. Among authors: alagappan vk. Int J Chron Obstruct Pulmon Dis. 2018 Mar 6;13:813-822. doi: 10.2147/COPD.S154012. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29563781 Free PMC article. Clinical Trial.
24 results